Test Code: PNL255

Comprehensive Detoxification & Immunogenetic Risk Panel

Rare-Diseases

This panel integrates key Phase II detoxification genes with critical immune regulation markers, offering a holistic view of how genetic variation influences toxin clearance, drug metabolism, cancer susceptibility, and autoimmune risk. It is designed for clinicians, researchers, and wellness programs seeking actionable insights into both metabolic resilience and immune predisposition

Sample Type

3 ml peripheral blood in EDTA (purple/pink top) tube

Turnaround Time

3 weeks days

Courier Requirements

Ship overnight at room temperature to receive next day. Do not refrigerate or freeze. Maintain specimen at room temperature.

Pricing

Genes Analyzed

11 genes

GSTP1:c.313A>G NQO1:c.559C>T GSTT1 GSTM1 CYP2D6 NAT2 UGT1A1 TPMT HLA‑DR15 HLA‑B*57:01 HLA‑B*27

Methodology

Capture-based target enrichment and Next Generation Sequencing.

Test Code PNL255
Category Rare-Diseases
Sample 3 ml peripheral blood in EDTA (purple/pink top) tube
TAT 3 weeks days
Courier Ship overnight at room temperature to receive next day. Do not refrigerate or freeze. Maintain specimen at room temperature.
Genes 11 genes analyzed

Need Help with This Test?

Our team of board-certified genomic scientists is available to answer your questions about test selection, sample requirements, and result interpretation.

Schedule a Consultation Call Us